BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37370009)

  • 1. Oxalate nephropathy in an elderly patient with newly diagnosed celiac disease - a case report.
    Zijlstra HW; Stegeman CA
    BMC Nephrol; 2023 Jun; 24(1):189. PubMed ID: 37370009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purslane-induced oxalate nephropathy: case report and literature review.
    Wang X; Zhang X; Wang L; Zhang R; Zhang Y; Cao L
    BMC Nephrol; 2023 Jul; 24(1):207. PubMed ID: 37443012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and Management of Hyperoxaluria and Oxalate Nephropathy: A Review.
    Demoulin N; Aydin S; Gillion V; Morelle J; Jadoul M
    Am J Kidney Dis; 2022 May; 79(5):717-727. PubMed ID: 34508834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hidden cause of oxalate nephropathy: a case report.
    Mahmoud T; Ghandour EC; Jaar BG
    J Med Case Rep; 2021 Mar; 15(1):106. PubMed ID: 33678172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.
    Ligon CB; Hummers LK; McMahan ZH
    Semin Arthritis Rheum; 2015 Dec; 45(3):315-20. PubMed ID: 26239907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute oxalate nephropathy causing late renal transplant dysfunction due to enteric hyperoxaluria.
    Rankin AC; Walsh SB; Summers SA; Owen MP; Mansell MA
    Am J Transplant; 2008 Aug; 8(8):1755-8. PubMed ID: 18557738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary hyperoxaluria due to pancreatic insufficiency.
    de Martines DGL; Gianotten S; F M Wetzels J; G van der Meijden WA
    Neth J Med; 2019 Oct; 77(8):287-292. PubMed ID: 31814577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute oxalate nephropathy associated with
    Pandey D; Verma A; Ding Y; Singh P; Magoo H
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31811106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute oxalate nephropathy due to pancreatic atrophy in newly diagnosed pancreatic carcinoma.
    Moinuddin I; Bala A; Ali B; Khan H; Bracamonte E; Sussman A
    Hum Pathol; 2016 Feb; 48():163-6. PubMed ID: 26614399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of Hyperoxaluria and Kidney Disease after Combined Intestine-Kidney Transplantation for Enteric Hyperoxaluria.
    Ekser B; Mangus RS; Kubal CA; Fridell JA; Powelson JA; Nagaraju S; Mihaylov P; Phillips CL; Saxena R; Goggins WC
    Am J Nephrol; 2016; 44(2):85-91. PubMed ID: 27410399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Oxalate Nephropathy: When a Single Cause Is Not Crystal Clear.
    Marques S; Santos S; Fremin K; Fogo AB
    Am J Kidney Dis; 2017 Nov; 70(5):722-724. PubMed ID: 28739328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Green Smoothie Cleanse" Causing Acute Oxalate Nephropathy.
    Makkapati S; D'Agati VD; Balsam L
    Am J Kidney Dis; 2018 Feb; 71(2):281-286. PubMed ID: 29203127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary oxalate nephropathy and kidney transplantation.
    Aziz F; Jorgenson M; Garg N
    Curr Opin Organ Transplant; 2023 Feb; 28(1):15-21. PubMed ID: 36342385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric hyperoxaluria: a hidden cause of early renal graft failure in two successive transplants: spontaneous late graft recovery.
    Cuvelier C; Goffin E; Cosyns JP; Wauthier M; de Strihou Cv
    Am J Kidney Dis; 2002 Jul; 40(1):E3. PubMed ID: 12087589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxalate nephropathy due to 'juicing': case report and review.
    Getting JE; Gregoire JR; Phul A; Kasten MJ
    Am J Med; 2013 Sep; 126(9):768-72. PubMed ID: 23830537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption.
    Stauffer JQ
    Am J Dig Dis; 1977 Oct; 22(10):921-8. PubMed ID: 920694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome.
    Emmett M; Guirl MJ; Santa Ana CA; Porter JL; Neimark S; Hofmann AF; Fordtran JS
    Am J Kidney Dis; 2003 Jan; 41(1):230-7. PubMed ID: 12500242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute oxalate nephropathy due to high vitamin C doses and exocrine pancreatic insufficiency.
    Fijen L; Weijmer M
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31748360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxalate nephropathy in a diabetic patient after gastric by-pass.
    Moutzouris DA; Skaneli G; Margellos V; Apostolou T; Petraki C; Nikolopoulou N
    Clin Nephrol; 2011 Feb; 75 Suppl 1():16-9. PubMed ID: 21269587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of patients with enteric hyperoxaluria.
    Asplin JR
    Urolithiasis; 2016 Feb; 44(1):33-43. PubMed ID: 26645872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.